HIGHLIGHTS
- who: Peng Cao from the GlaxoSmithKline, United Kingdom , Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China, State Key Laboratory of have published the research: TGF-u03b2 Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting A, in the Journal: (JOURNAL)
- what: The authors intended to characterize the features of TGF-b + GMCSF as potential inducing factors to promote the differentiation of the precursor cells from the bone marrow into MDSCs. The work showed that after addition of TGF-b, the expression level of Arg-1 was noted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.